Ravgen: Difference between revisions
DNA Doctor (talk | contribs) added controversy section |
DNA Doctor (talk | contribs) |
||
| Line 51: | Line 51: | ||
Ravgen has made no further announcement since 2007 with regards to their success towards creating a viable commercial non-invasive prenatal [[Down’s Syndrome]] test, their web site shows no recent information. |
Ravgen has made no further announcement since 2007 with regards to their success towards creating a viable commercial non-invasive prenatal [[Down’s Syndrome]] test, their web site shows no recent information. |
||
Ravgen's ability to be impartial with regards to quality business decisions is questionable due to what appears to be unqualified individuals on their [[board of directors]] resulting from [[nepotism]]. The board of directors majority voting block consists of [[Ravinder Dhallan]], his brother Narender Dhallan<ref>http://www.ravgen.com/index.php?page=board-of-directors</ref>, and his sister Kamlesh Miller<ref>http://www.ravgen.com/index.php?page=board-of-directors</ref>. The listed qualifications of each sibling are as follows: |
Ravgen's ability to be impartial with regards to quality business decisions is questionable due to what appears to be unqualified individuals on their [[board of directors]] resulting from [[nepotism]]. The board of directors majority voting block consists of [[Ravinder Dhallan]], his brother Narender Dhallan<ref>http://www.ravgen.com/index.php?page=board-of-directors</ref>, and his sister Kamlesh Miller<ref>http://www.ravgen.com/index.php?page=board-of-directors</ref>. The listed qualifications of each sibling are as follows: |
||
Narender Dhallan, B.S. |
Narender Dhallan, B.S. |
||
| Line 60: | Line 60: | ||
Pharmacist |
Pharmacist |
||
Ms. Miller earned a B.S. in Pharmacy as well as a B.S. in Nursing from the University of Maryland at Baltimore. Ms. Miller served as a staff nurse at the AMI Doctors' Hospital in both the Medical Surgical Unit and Intensive Care Units, before receiving her B.S. in Pharmacy in 1990. She has since served as a staff pharmacist and consultant in various area hospitals, most recently with Pharmacy Corporation of America. |
Ms. Miller earned a B.S. in Pharmacy as well as a B.S. in Nursing from the University of Maryland at Baltimore. Ms. Miller served as a staff nurse at the AMI Doctors' Hospital in both the Medical Surgical Unit and Intensive Care Units, before receiving her B.S. in Pharmacy in 1990. She has since served as a staff pharmacist and consultant in various area hospitals, most recently with Pharmacy Corporation of America. |
||
==References== |
==References== |
||
Revision as of 03:19, 12 April 2010
| Company type | Private |
|---|---|
| Industry | Biotechnology |
| Founded | 1 January 2000  |
| Headquarters | Columbia, Maryland |
Key people | Ravinder Dhallan, CEO |
| Website | www.ravgen.com |
Ravgen Inc., was founded by Dr. Ravinder Dhallan who is also Chairman and C.E.O. Dr. Dhallan earned his M.D. and Ph.D. from The Johns Hopkins University School of Medicine in Baltimore, MD, and his MBA from The Wharton School of Business at the University of Pennsylvannia. Ravgen Inc. has developed a non-invasive prenatal diagnosis testing which was published in The Lancet (Lancet. 2007; 369:474-81)[1] as well as The Journal of the American Medical Association (JAMA. 2004;291:1114-1119)[2]. These publications received world wide press in The London Times, Washington Post, CNN, and Fortune Small Business (Sept. 2007)[3].
Ravgen Diagnostics is a company founded in the fall of 2007 offering state of the art genetic testing based on their proprietary Ravgen method (Rapid Analysis of Variations in the Genome) which was developed by Ravgen.
Timeline
- fall 2000: Ravgen founded.
- March 2004: Ravgen publishes first clinical study in JAMA
- February 2007: Ravgen publishes second clinical study in the Lancet
- fall 2007: Ravgen Diagnostics founded
Competition
Companies and universities that are working towards developing non-invasive prenatal testing include Sequenom, Artemis Health[4], Lenetix[5], Fluidigm[6], and Stanford University[7].
Media Coverage
Ravgen has received local[8] and global[9] media coverage of their non-invasive prenatal DNA testing. To date coverage appears to be oriented towards reporting public relations news directly from Ravgen. No known documentary exists that specifically challenges the science behind Ravgen's methodologies.
Controversy
Ravgen has made no further announcement since 2007 with regards to their success towards creating a viable commercial non-invasive prenatal Down’s Syndrome test, their web site shows no recent information.
Ravgen's ability to be impartial with regards to quality business decisions is questionable due to what appears to be unqualified individuals on their board of directors resulting from nepotism. The board of directors majority voting block consists of Ravinder Dhallan, his brother Narender Dhallan[10], and his sister Kamlesh Miller[11]. The listed business qualifications of each sibling are as follows:
Narender Dhallan, B.S. Teacher Mr. Dhallan earned a B.S. in Pharmacy from the University of Maryland at Baltimore and a B.S. in Education from the University of Maryland at College Park. Mr. Dhallan has seven years experience as a pharmacist, and is currently a teacher, instructing high school seniors in AP physics and AP chemistry in Germantown, Maryland.
Kamlesh Miller, R.N., B.S. Pharmacist Ms. Miller earned a B.S. in Pharmacy as well as a B.S. in Nursing from the University of Maryland at Baltimore. Ms. Miller served as a staff nurse at the AMI Doctors' Hospital in both the Medical Surgical Unit and Intensive Care Units, before receiving her B.S. in Pharmacy in 1990. She has since served as a staff pharmacist and consultant in various area hospitals, most recently with Pharmacy Corporation of America.
References
- ^ http://www.thelancet.com/journals/lancet/article/PIIS0140673607601159/abstract
- ^ http://jama.ama-assn.org/cgi/content/abstract/291/9/1114
- ^ http://money.cnn.com/2007/09/07/smbusiness/amniocentesis.fsb/
- ^ http://www.artemishealthinc.com
- ^ http://www.medicalnewstoday.com/articles/138062.php
- ^ http://www.businessweek.com/news/2010-02-22/fidelity-backed-fluidigm-may-delay-ipo-as-startup-deals-falter.html
- ^ http://www.bionews.org.uk/page_13538.asp
- ^ http://www.wusa9.com/rss/local_article.aspx?storyid=55510
- ^ http://news.bbc.co.uk/2/hi/health/6320273.stm
- ^ http://www.ravgen.com/index.php?page=board-of-directors
- ^ http://www.ravgen.com/index.php?page=board-of-directors
External links
 | This biotechnology article is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 | This United States corporation or company article is a stub. You can help Wikipedia by expanding it. |